Internal Checkpoint Regulates T Cell Neoantigen Reactivity and Susceptibility to PD1 Blockade
bioRxiv preprint doi: https://doi.org/10.1101/2020.09.24.306571; this version posted September 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade Douglas C. Palmer1*§, Beau R. Webber2,3,4*§, Yogin Patel1, Matthew J. Johnson2,3,4, Christine M. Kariya1, Walker S. Lahr2,3,4, Maria R. Parkhurst1, Jared J Gartner1, Todd D Prickett1, Frank J. Lowery1, Rigel J. Kishton1, Devikala Gurusamy1, Zulmarie Franco1, Suman K. Vodnala1, Miechaleen D. Diers2,3,4, Natalie K. Wolf2,3,4, Nicholas J. Slipek2,3,4, David H. McKenna5, Darin Sumstad6, Lydia Viney7, Tom Henley7, Tilmann Bürckstümmer7, Oliver Baker7, Ying Hu8, Chunhua Yan8, Daoud Meerzaman8, Kartik Padhan9, Winnie Lo1, Parisa Malekzadeh1, Li Jia1, Drew C. Deniger1, Shashank J. Patel1, Paul F. Robbins1, R. Scott McIvor1,10, Modassir Choudhry7, Steven A. Rosenberg1*§, Branden S. Moriarity2,3,4*§, Nicholas P. Restifo1*§ 1Surgery Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA. 2Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA. 3Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. 4Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA. 5Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA. 6Molecular and Cellular Therapeutics, University of Minnesota, Saint Paul, Minnesota, USA. 7Intima Bioscience, Inc. New York, NY, USA. 8The Center for Biomedical Informatics and Information Technology (CBIIT), National Institutes of Health, Bethesda, Maryland, USA, 9National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
[Show full text]